Wordt geladen...
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors
BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/ https://ncbi.nlm.nih.gov/pubmed/20507929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|